Can Alpelisib treat lung adenocarcinoma?

Alpelisib (Alpelisib) is mainly used to treat breast cancer, especially a specific subtype of breast cancer, namely hormone receptor-positive (PIK3CA mutation an>HR-positive) and human epidermal growth factor receptor2-negative (HER2-negative) advanced breast cancer. Apelvis blocks the growth and division of cancer cells by inhibiting the PI3K signaling pathway triggered by PIK3CA gene mutations.

However, lung adenocarcinoma is often a subtype of lung cancer and has different pathophysiology and molecular biology than breast cancer. There is insufficient evidence to support the effectiveness of Apelvis in the treatment of lung adenocarcinoma. Treatment options for lung adenocarcinoma usually include surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy and other methods. The specific choice depends on the patient's condition, molecular biology characteristics, disease stage and other factors.

In the field of medical research, the development of treatment strategies and new drugs is ongoing, so it is recommended to consult a professional doctor or lung cancer expert to obtain the latest treatment information. At the same time, clinical trials are also a way to learn about the effects of new treatments and drugs. Patients and doctors can work together to discuss whether there are appropriate clinical trials for the patient's condition to better individualize treatment options.

Apelis has not yet been launched in China, so it is not included in the medical insurance. Therefore, patients cannot purchase it domestically yet and need to purchase Apelis through overseas channels. In foreign countries, the original Apelvis drug is mainly used. There are European and Indian versions of the original drug on the market. The price of the European version of the original drug is as high as tens of thousands of yuan. Relatively speaking, the price of the Indian version of the original drug is around four to five thousand yuan. The price is still relatively cheap. Moreover, the ingredients and efficacy of the European and Indian original drugs are consistent.